Vizsgálati helyszín
Tangdu Hospital
Xi'an, Shaanxi 710038, KínaMég nincs intézményhez kötve
- 18futó vizsgálat
- 11lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 29 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis7 vizsgálat
- 1/2. fázis3 vizsgálat
- 2. fázis3 vizsgálat
- 2/3. fázis1 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Toboroz14 vizsgálat
- Lezárult10 vizsgálat
- Fut, nem toboroz2 vizsgálat
- Még nem toboroz2 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Tang-Du Hospital17 vizsgálat
- Xijing Hospital4 vizsgálat
- Janssen Research & Development, LLC2 vizsgálat
- Denovo Biopharma LLC1 vizsgálat
- Hoffmann-La Roche1 vizsgálat
- és még 4
Futó vizsgálatok
Még nem toboroz
A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC
NCT07705126· Tang-Du Hospital· Forrás
Contact: Xin Wang
Toboroz
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
NCT07516522· 2. fázis· Tang-Du Hospital· Forrás
Contact: Wei Guo, MD
Toboroz
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
NCT07354061· 1/2. fázis· Tang-Du Hospital· Forrás
Contact: Zhang
Toboroz
Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07377305· Tang-Du Hospital· Forrás
Contact: Jun GUO, Dr
Toboroz
Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion
NCT07141303· 3. fázis· Tang-Du Hospital· Forrás
Contact: Wei Guo, MD
Toboroz
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
NCT06979869· Xijing Hospital· Forrás
Contact: Xianchun Gao, doctor
Toboroz
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
NCT06979895· Xijing Hospital· Forrás
Contact: Xianchun Gao, doctor
Toboroz
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
NCT06864624· 2. fázis· Tang-Du Hospital· Forrás
Contact: Shicao Li
Toboroz
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
NCT06447597· 2/3. fázis· Shanghai Jiaolian Drug Research and Development Co., Ltd· Forrás
Contact: Ting Chang
Toboroz
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
NCT06467786· 4. fázis· Tang-Du Hospital· Forrás
Contact: Haichuan Su, PhD
Toboroz
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
NCT06231264· Xijing Hospital· Forrás
Contact: Ning Wang
Fut, nem toboroz
fMRI Study of the Neural Mechanism of rTMS in the Treatment of Nicotine Dependence
NCT06762535· Tang-Du Hospital· Forrás
Fut, nem toboroz
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB Resectable NSCLC (FORESEE)
NCT05430802· 2. fázis· Tang-Du Hospital· Forrás
Toboroz
Ofatumumab in AQP4-IgG Seropositive NMOSD
NCT05504694· 1/2. fázis· Tang-Du Hospital· Forrás
Contact: Jun Guo, M.D.
Toboroz
Assessment of Brain Cognitive Impairment in Breast Cancer
NCT05305092· Tang-Du Hospital· Forrás
Contact: Menghui Yuan, PHD
Toboroz
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053· Xijing Hospital· Forrás
Contact: Wei Zhang
Toboroz
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
NCT03093116· 1/2. fázis· Turning Point Therapeutics, Inc.· Forrás
Contact: Haichuan Su, Site 6754
Toboroz
The Early Warning System for the Diabetic Encephalopathy
NCT02420470· Tang-Du Hospital· Forrás
Contact: Ying Yu, master
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
3D-Printed Artificial Airway Fixation Device for Obese Patients
NCT07349433· Tang-Du Hospital· Forrás
Lezárult
Optimizing Early Nutrition Support in Severe Stroke-2
NCT05998902· 3. fázis· Wen Jiang-3· Forrás
Lezárult
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
NCT06196723· Tang-Du Hospital· Forrás
Lezárult
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
NCT06245798· Tang-Du Hospital· Forrás
Lezárult
Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
NCT06245785· Tang-Du Hospital· Forrás
Lezárult
Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A Retrospective Study Using the SEER Database and Chinese Data
NCT06199388· Tang-Du Hospital· Forrás
Leállították
A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
NCT04963270· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
NCT03776071· 3. fázis· Denovo Biopharma LLC· Forrás
Lezárult
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
NCT04846491· 3. fázis· Xiamen Amoytop Biotech Co., Ltd.· Forrás
Lezárult
A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
NCT03234972· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)
NCT03217812· 3. fázis· Janssen Research & Development, LLC· Forrás
Hibát jelzek